PEDMARQSI® (sodium thiosulfate solution for infusion) becomes the first and only treatment authorised in Switzerland for the prevention of cisplatin-induced ototoxicity (hearing loss) in patients aged 1 month to
Hence then, the article about norgine announces swissmedic approval of pedmarqsi for the prevention of cisplatin induced hearing loss in children was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children )
Also on site :
- Ricky Gervais Talks Netflix’s ‘Alley Cats’ as Annecy Sings Him ‘Happy Birthday’: ‘I Hope You Like Cats. And Swearing’
- Brutal killing of French teen by ‘migrant gang’ sparks national outrage (GRAPHIC FOOTAGE)
- Michael Kors' 'Beautiful' Shoulder Bag Is Now 65% Off at Amazon for Prime Day, and It’s the 'Perfect Everyday Tote'